TEVA

D TEVA PHARM ADRS

14 superinvestors own TEVA

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
William Von Mueffling	Cantillon Capital Management	5.57%	5,157,725	$238.2M	2008Q1	Added
Harry Burn	Sound Shore	3.92%	3,885,683	$117.0M	2026Q1	Reduced
David Abrams	Abrams Capital Management	1.95%	5,996,836	$62.6M	2023Q4	Reduced
David Katz	Matrix Asset Advisors	1.60%	261,000	$9.5M	2016Q4	Added
David Einhorn	Greenlight Capital	0.14%	268,470	$2.8M	2023Q4	New
Warren Buffett	Berkshire Hathaway	0.14%	42,789,295	$416.8M	2021Q3	Held
Viking Global Investors	Viking Global Investors	0.13%	2,532,119	$51.1M	2025Q3	Reduced
Samantha McLemore	Patient Capital Management	0.10%	100,000	$2.2M	2024Q4	Held
Bill Miller	Miller Value Partners	0.10%	10,950	$241K	2024Q4	Held
Meridian / ArrowMark	Meridian Contrarian Fund	0.09%	1,079,000	$12.5M	2021Q1	Added
Bill Nygren	Oakmark Select Fund – Harris Associates	0.01%	4,350	$215K	2009Q2	Reduced
Kenneth Fisher	Fisher Asset Management	0.00%	10,625	$258K	2018Q2	Reduced
Dodge & Cox	Dodge & Cox	0.00%	7,350	$316K	2005Q4	Reduced
First Eagle Investment Management	First Eagle Investment Management	0.00%	200	$4K	2017Q4	Held

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind TEVA activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.